![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C12N 15/11 | |
C12N 15/113 | |||
A61K 31/7125 | |||
A61K 31/713 |
(11) | Patento numeris | 2780353 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 12850255.6 |
Europos patento paraiškos padavimo data | 2012-11-16 | |
(97) | Europos patento paraiškos paskelbimo data | 2014-09-24 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2017-08-16 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2012/065691 |
Data | 2012-11-16 |
(87) | Numeris | WO 2013/075035 |
Data | 2013-05-23 |
(30) | Numeris | Data | Šalis |
201161561710 P | 2011-11-18 | US | |
201261615618 P | 2012-03-26 | US | |
201261680098 P | 2012-08-06 | US |
(72) |
RAJEEV, Kallanthottathil, G., US
ZIMMERMANN, Tracy, US
MANOHARAN, Muthiah, US
MAIER, Martin, US
KUCHIMANCHI, Satyanarayana, US
CHARISSE, Klaus, US
|
(73) |
Alnylam Pharmaceuticals, Inc.,
300 Third Street, 3rd Floor, Cambridge, MA 02142,
US
|
(54) | RNAI AGENTS, COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING TRANSTHYRETIN (TTR) ASSOCIATED DISEASES |
RNAI AGENTS, COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING TRANSTHYRETIN (TTR) ASSOCIATED DISEASES |